Atticus Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2
Closed -$1.05K 525
2025
Q2
$1.05K Buy
+2
New +$1.12K ﹤0.01% 599
2023
Q1
Sell
-3
Closed -$2.16K 577
2022
Q4
$2.16K Sell
3
-6
-67% -$4.43K ﹤0.01% 460
2022
Q3
$5K Hold
9
﹤0.01% 439
2022
Q2
$5K Hold
9
﹤0.01% 471
2022
Q1
$6K Buy
9
+4
+80% +$2.53K ﹤0.01% 453
2021
Q4
$3K Sell
5
-61
-92% -$37.5K ﹤0.01% 407
2021
Q3
$40K Sell
66
-2
-3% -$1.24K 0.02% 260
2021
Q2
$38K Hold
68
0.02% 251
2021
Q1
$32K Sell
68
-58
-46% -$28.2K 0.02% 242
2020
Q4
$61K Hold
126
0.03% 192
2020
Q3
$71K Hold
126
0.04% 159
2020
Q2
$79K Buy
126
+3
+2% +$1.7K 0.05% 144
2020
Q1
$60K Buy
+123
New +$50.7K 0.05% 162

Other funds holding REGN